Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease

Background. Fecal microbiota transplantation (FMT) is a well-established therapeutic option for patients with antibiotic resistant Clostridioides difficile infection (CDI). However, the efficacy of FMT in patients with chronic liver disease remains elusive. Aims. We studied the effect of FMT on chro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alireza Meighani, Maryam Alimirah, Mayur Ramesh, Reena Salgia
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	International Journal of Hepatology
Online Access:	http://dx.doi.org/10.1155/2020/1874570
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
by: Elvira Garza-González, et al.
Published: (2019-01-01)

Zinc Deficiency and the Recurrence of Clostridium difficile Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study
by: Blake A. Niccum, et al.
Published: (2018-01-01)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
by: Laura Tijerina-Rodríguez, et al.
Published: (2019-01-01)

Gastroenterological Surgery and Management of Clostridioides difficile Infection: A Review
by: Tomonori Takano, et al.
Published: (2025-01-01)

A Review of Therapies for <i>Clostridioides difficile</i> Infection
by: Faiza Morado, et al.
Published: (2024-12-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
by: Roberto Rosato, et al.
Published: (2024-12-01)

Clinical characteristics and risk factors of Clostridioides difficile infection in children with diarrhoea
by: Ning Wang, et al.
Published: (2025-02-01)

Efficacy and Safety of, and Patient Satisfaction with, Colonoscopic-Administered Fecal Microbiota Transplantation in Relapsing and Refractory Community- and Hospital-Acquired Clostridium difficile Infection
by: Muhammad Ali Khan, et al.
Published: (2014-01-01)

Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
by: Pedro Puerta-Alcalde, et al.
Published: (2025-04-01)

Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
by: A. Y. Tikunov, et al.
Published: (2020-04-01)

Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis
by: Katharina Schley, et al.
Published: (2024-11-01)

Caring at the transition: success and financial barriers of fidaxomicin discharge prescriptions for inpatients with Clostridioides difficile infection
by: Ellen Earle, et al.
Published: (2025-01-01)

Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era
by: Helena Martínez-Lozano, et al.
Published: (2025-02-01)

Global burden and trends of the Clostridioides difficile infection-associated diseases from 1990 to 2021: an observational trend study
by: Jun Xia, et al.
Published: (2025-12-01)

Using fecal microbiota transplantation for animal health (review)
by: H. Yu. Drobot, et al.
Published: (2024-12-01)

Effect of a single rectal fecal microbiota transplantation on clinical severity and fecal microbial communities in dogs with chronic inflammatory enteropathy
by: Jorge Pérez‐Accino, et al.
Published: (2025-01-01)

Abundant geographical divergence of Clostridioides difficile infection in China: a prospective multicenter cross-sectional study
by: Lulu Bai, et al.
Published: (2025-02-01)

Fecal Microbiota and Diet of Children with Chronic Constipation
by: Joyce Gomes de Moraes, et al.
Published: (2016-01-01)

Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets
by: Shankumar Mooyottu, et al.
Published: (2025-02-01)

Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country
by: Tae-Geun Gweon, et al.
Published: (2016-01-01)

The Effect of Fecal Microbiota Transplantation on a Child with Tourette Syndrome
by: Huijun Zhao, et al.
Published: (2017-01-01)

Fecal microbiota transplantation alleviates radiation enteritis by modulating gut microbiota and metabolite profiles
by: Qin Ding, et al.
Published: (2025-02-01)

The Efficacy of Fecal Microbiota Transplantation in Experimental Autoimmune Encephalomyelitis: Transcriptome and Gut Microbiota Profiling
by: Sanwang Wang, et al.
Published: (2021-01-01)

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease
by: Yao Wei, et al.
Published: (2015-01-01)

Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.
by: Christopher Mitchell, et al.
Published: (2024-01-01)

Severe Diverticulitis Associated to <i>Clostridioides difficile</i> Infection in a 91 Year Old Patient (Clinical Case)
by: A. A. Makushina, et al.
Published: (2022-08-01)

Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against <i>Clostridioides difficile</i> Infection
by: Shaohui Wang, et al.
Published: (2024-12-01)

Modern Approaches to the Diagnosis and treatment of <i>Clostridioides difficile (C. difficile)</i>-associated Disease in Adults (literature Review and Expert Council Resolution)
by: V. T. Ivashkin, et al.
Published: (2023-08-01)

Impact of empiric antibiotics on risk of Clostridioides difficile—a causal inference observational analysis
by: Matthew A. Pappas, et al.
Published: (2025-01-01)

Heterogeneity of Clostridioides difficile asymptomatic colonization prevalence: a systematic review and meta-analysis
by: Daniel De-la-Rosa-Martínez, et al.
Published: (2025-01-01)

Basic Molecular Biology, Metabolic and Immunological Mechanisms of Fecal Microbiota Transplantation
by: O. V. Goloshchapov, et al.
Published: (2024-12-01)

Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis
by: Kanglan Li, et al.
Published: (2020-01-01)

The role of fecal microbiota transplantation in type 2 diabetes mellitus treatment
by: Huimei Wang, et al.
Published: (2024-12-01)

Metronidazole and Vancomycin Have a Synergic Effect, with Plant Extracts as Helpful Tools to Combat <i>Clostridioides difficile</i> Infections
by: Nancy C. Ruiz-Pérez, et al.
Published: (2025-01-01)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
by: Stefano Bibbò, et al.
Published: (2014-01-01)

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain
by: Hao-Ming Xu, et al.
Published: (2021-01-01)

Corrigendum: The role of fecal microbiota transplantation in type 2 diabetes mellitus treatment
by: Huimei Wang, et al.
Published: (2025-01-01)

Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect
by: Swetha Reddi, et al.
Published: (2025-01-01)

Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut–brain axis
by: Mahdis Morshedbak, et al.
Published: (2025-02-01)